Catalyst Event
Gilead Sciences Inc (GILD) · Other
From KEDI Palantir Fixed Tech100 Index (KPLTT100)
5/22/2026, 12:00:00 AM
Received a positive opinion from the European Medicines Agency's CHMP for Trodelvy for the first-line treatment of a specific subgroup of metastatic triple-negative breast cancer (mTNBC). Estimated price impact is ≥1% due to positive regulatory progress.
Korean Translation
전이성 삼중음성 유방암(mTNBC)의 특정 하위 그룹에 대한 1차 치료제로 트로델비에 대해 유럽의약품청(EMA)의 약물사용자문위원회(CHMP)로부터 긍정적 의견을 받음. 긍정적인 규제 진전으로 인해 1% 이상의 주가 영향이 예상됨.
Related Recent Events
Apple Inc (AAPL) · Other
CEO Tim Cook is scheduled to transition to the role of Executive Chair, with John Ternus, current SVP of Hardware Engineering, becoming the new CEO on September 1, 2026, which analysts forecast will result in a ~5% price impact, scheduled.
9/1/2026, 12:00:00 AM
Cisco Systems Inc (CSCO) · Earnings Release
Cisco's Q4 FY2026 earnings release is scheduled for August 12, 2026, based on past reporting schedules; high volatility is expected.
8/12/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
AMD Q2 2026 earnings release and $11.2B revenue guidance (46% YoY growth); medium importance justified by estimated >=5% price impact scheduled.
8/4/2026, 12:00:00 AM
Amazon.com Inc (AMZN) · Earnings Release
Amazon's Q2 2026 earnings release is scheduled for July 30, 2026, where analysts forecast an EPS of approximately $1.81-$1.82. Medium importance is estimated as earnings releases typically trigger 5-10% price volatility forecasted.
7/30/2026, 12:00:00 AM
Comcast Corp (CMCSA) · Earnings Release
Comcast is scheduled to release its Q2 2026 earnings results on 2026-07-30. Analysts forecast earnings of approximately $0.99 per share. A price impact of ≥5% is estimated based on historical earnings volatility, scheduled.
7/30/2026, 12:00:00 AM
Sanofi (SNY) · Earnings Release
Sanofi is scheduled to release its Q2 2026 financial results on July 30, 2026; a 1-5% impact is estimated as the market anticipates the report, scheduled.
7/30/2026, 12:00:00 AM